Argus downgraded Teva Pharma (NYSE: TEVA) from Buy to Hold.Analyst John Eade comments "We are downgrading Teva Pharmaceutical Industries Ltd ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE